Aeroflex Neu (AERONEU)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Low leverage: Debt/Equity is only 0.27, so the balance sheet is not strained.
• Promoter holding of 60.46% aligns management interests with minority shareholders.
• Piotroski F-Score of 6/9 suggests recent financial health is acceptable despite weak profitability.
• Latest quarter is profitable: ₹1 Cr net profit on ₹31 Cr sales, so there is no immediate distress.

Concerns

• Valuation is steep: P/E of 81.76 and P/B of 2.50 stand against an ROE of just 2.02% and ROCE of 3.42%.
• Sales declined 4.48% year-on-year; the reported 1,000% profit growth is off a tiny base, not evidence of durable demand.
• No dividend yield means shareholders receive no cash return while waiting for uncertain growth.
• Latest quarterly net margin of roughly 3.2% is thin for a packaging business with likely low pricing power.

AI Analysis

At ₹79.16, the market is asking me to pay ₹181 Cr for a packaging company earning roughly ₹1 Cr in its latest quarter. That is an 81.76 times trailing earnings multiple. Graham would remind me that a thousand percent profit growth is an arithmetic curiosity when the base is a single crore of quarterly profit; it tells me nothing about durability. Sales actually fell 4.48%, and the latest quarter's net margin works out to barely 3.2%. A business earning 2.02% return on equity and 3.42% return on capital cannot justify a 2.50 times book value unless something fundamental changes. Low debt of 0.27 debt-to-equity is good, and promoter holding of 60.46% aligns owners with management, but those are not moats. Packaging is a competitive, low-differentiation industry; there is no pricing power visible in these numbers. The Piotroski score of 6 suggests short-term financial health has not deteriorated, but it is not a buy signal at this price. The zero dividend means my only return would have to come from re-rating or much higher earnings, and the current sales trend is moving in the other direction. I need evidence of a genuine turnaround—quarter after quarter of rising sales, expanding margins, and return on equity moving toward a real cost of equity. Until then, I would rather watch from the sidelines. Price is what you pay; value is what you get. At ₹79.16, I see too much price and too little proven value.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer